Conservative Management of Functional Bowel & Pelvic Floor Disorders

Similar documents
GI Physiology - Investigating and treating patients with pelvic floor dysfunction. Lynne Smith Department of GI Physiology NGH Sheffield

Faecal Incontinence: Assessment and Management

Pelvic Floor Disorders. Amir Darakhshan MD FRCS (Gen Surg) Consultant Colorectal and General Surgeon

PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/d Colorectal: Faecal Incontinence (Adult)

Percutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms. Patient Information Leaflet

University College Hospital at Westmoreland Street. Percutaneous Tibial Nerve Stimulation (PTNS)

Lets talk about Faecal incontinence (FI) in Scleroderma

Tertiary, regional and local pelvic floor service providers: the future. model? Andrew Williams

A70.4 Insertion of neurostimulator electrodes into peripheral nerve Z12.2 Posterior tibial nerve R15.X Faecal incontinence

SACRAL NERVE STIMULATION FOR EXPERIENCE IN CHILDREN

Prolapse & Urogynaecology. Hester Mannion and Fabi Sica

Managing Female Urinary Incontinence Within Primary Care

Randomised Mixed Methods Pilot Trial of Sacral and Percutaneous Tibial Nerve Stimulation for Faecal Incontinence

URINARY INCONTINENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Updates in the nonpharmacological. treatment on overactive bladder

Biofeedback Therapy A nurse led management service for functional bowel disorders

Posterior Tibial Nerve Stimulation

Faecal Incontinence Information Leaflet THE DIGESTIVE SYSTEM

Sacral Nerve Stimulation for Faecal Incontinence

A Case of Fecal Incontinence: Medical and Interventional Treatment Options

Sacral Neuromodulation Beyond Pelvic Pain!!!

2/5/2016. Evolving Surgical Treatment Approaches for Fecal Incontinence in Women: An Evidence and Cased-Based Approach

03/13/18. A. Symptoms lasting for greater than or equal to 12 months that have resulted to significant impairment in activities of daily living; and

Bladder dysfunction in ALD and AMN

Incidence of Colorectal Cancers- Australia. Anterior Resection 5/23/2018. What spurs us to investigate?

Index. Note: Page numbers of article titles are in boldface type.

Various Types. Ralph Boling, DO, FACOG

ACCIDENTAL BOWEL LEAKAGE: A PRACTICAL APPROACH TO EVALUATION. Tristi W. Muir, MD Chair, Department of OB/GYN Houston Methodist Hospital

Module 5 Management Of Urinary Incontinence

PERCUTANEOUS TIBIAL NERVE STIMULATION

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women

Novel Options for the Management of Fecal Incontinence

Continence Promotion in

Duc M. Vo, MD, FACS Northwest Surgical Specialists

Advanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa

Biofeedback for pouch dysfunction. Brigitte Collins, Lead Nurse BSc (Hons), MSc GI Nursing, Dip/ Hypnotherapy

Regaining Bowel Control. Yvette Perston Functional Bowel CNS Queen Elizabeth Hospital Birmingham

CONTINENCE MODULE 1 MIMIMUM STANDARDS FOR THE SPECIALIST ASSESSMENT & CONSERVATIVE MANAGEMENT OF FEMALE LOWER URINARY TRACT SYMPTOMS

Fecal Incontinence. What is fecal incontinence?

Sacral Nerve Neuromodulation/Stimulation

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS) POLICY NUMBER: CATEGORY: Technology Assessment

Your guidebook for getting results with Medtronic Bladder Control Therapy Delivered by the NURO System TAKE BACK CONTROL.

Pelvic Floor Exercises

Management of Neurogenic Bowel Dysfunction. Fiona Paul, DNP, RN, CPNP Center for Motility and Functional Gastrointestinal Disorders

OHTAC Recommendation

Priorities Forum Statement GUIDANCE

Bowel Disease Research Foundation

Clinical problems related to GI involvement in SSc

DOWNLOAD OR READ : URINARY FECAL INCONTINENCE CURRENT MANAGEMENT CONCEPTS URINARY AND FECAL INCONTINENCE PDF EBOOK EPUB MOBI

Stress Incontinence. Susannah Elvy Urogynaecology CNS

Bill Landry BScPT, BScH, MCPA, CAFCI Family Physiotherapy Centre of London

Stapled transanal rectal resection for obstructed defaecation syndrome

CONSERVATIVE MANAGEMENT OF URINARY INCONTINENCE IN WOMEN. Riette Vosloo Physiotherapist in Women s s Health

Case Study: Abdominal & Pelvic Pain

Diagnosis and Treatment of Urinary Incontinence. Urinary Incontinence

PERCUTANEOUS TIBIAL NERVE STIMULATION

Overactive Bladder Syndrome

Overactive bladder syndrome (OAB)

A prospective multicentre study to investigate percutaneous tibial nerve stimulation for the treatment of faecal incontinence

Sacral Nerve Neuromodulation/Stimulation. Description

Anorectal Diagnostic Overview

Pelvic Floor Exercise. Brigi0e Fung Physiotherapist

Neuromodulation and the pudendal nerve

Sacral Nerve Neuromodulation / Stimulation

NEUROMODULATION FOR UROGYNAECOLOGISTS

The cost of the Axonics sacral neuromodulation system is 475 for the trial phase, 9,210 for a

15. Prevention of UTI and lifestyle modifications

BEST PRACTICE ADVOCACY CENTRE NEW ZEALAND SCOPE. Urinary incontinence in women: the management of urinary incontinence in women

Disease Management. Incontinence Care. Chan Sau Kuen Continence Nurse Consultant United Christian Hospital 14/11/09

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS)

Commissioning guide:

Promoting Continence with Physiotherapy

Management, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence

Sacral Nerve Neuromodulation/Stimulation. Description

URINARY INCONTINENCE FOR FALLS PREVENTION. by Susan Elms P.T. Elms Physiotherapy

MEDICAL POLICY SUBJECT: SACRAL NERVE STIMULATION

Incontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery

2/5/2016. ABS Complications. Anal Slings-investigational

Information about your operation: Sacral nerve stimulation (SNS)

Mrs Ami Shukla Consultant Gynaecologist and Obstetrician Lead Urogynaecologist, Northampton General Hospital Website:

Corporate Medical Policy

Treatments for Fecal Incontinence A Review of the Research for Adults

Continence Worksheet Name: Date: Name of Trainer: Name of Company: Clinical Update (NZ) Ltd

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

Colorectal Surgery Benign Anal Conditions...

The Praxis FES System and Bladder/Bowel Management in Patients with Spinal Cord Injury

Pelvic Floor Therapy for the Oncology Patient

Pregnancy related pelvic floor dysfunction- suggested teaching presentation for Midwives

Management of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals

Stimulation of the Sacral Anterior Root Combined with Posterior Sacral Rhizotomy in Patients with Spinal Cord Injury. Original Policy Date

Urinary Incontinence. Lora Keeling and Byron Neale

Incontinence: Risks, Causes and Care

A over-the-counter medical device that utilizes muscle stimulation for the treatment of stress, urge and mixed urinary incontinence.

Clinical Commissioning Policy Statement: Sacral Nerve Stimulation (SNS) for Faecal Incontinence in Adults April Reference: NHSCB/A08/PS/b

La vescica iperattiva: dalla diagnosi ai nuovi approcci terapeutici

John Laughlin 4 th year Cardiff University Medical Student

Transcription:

Conservative Management of Functional Bowel & Pelvic Floor Disorders Kathy Davis PhD BSc(Hons)SRN Specialist Nurse Consultant Parkside Hospital & Minerva Medical Clinic

Overview Burden of disease Aims Assessment Management & new technologies in FI

PFD is common (prev. 14-46%) Affects 1/3 rd of all women Affects bladder, bowel & sexual function >60% PF problems can be managed conservatively

Health burden and costs High level of unmet service need Significant costs- NHS bill for UI & FI estimated at 500 million PA on par with gynae ca, osteoporosis, pneumonia, flu, OA (Turner al BJU 2004) USA - PFD adult OPD visit = 0.9% of > women over 60 years (Sung et al 2009) Future demand for services over next 30 years expected to rise by 50% (Luber et al 2001)

AIMS OF TREATMENT Symptom improvement (primary outcome) Restoration of physiological function Correction of anatomical defect Improvement in QoL & social confidence

Challenge of Faecal Incontinence Multifactorial Pathophyisological mechanisms overlap Majority of patients (80%) have 1 or more underlying abnormalities (structure, function, stool characteristics)

Assessment Patients reluctant to discuss details specific questioning needed Onset Precipitating events Duration Severity History of constipation/ impaction Stool volume/consistency/urgency Ability to distinguish flatus, formed/unformed stool Coexisting medical conditions Medications, prescription/otc Diet/lifestyle -smoking, EtoH, caffeine Determine clinical subtype

Sub types of Faecal Incontinence Passive incontinence the involuntary discharge of feacal matter or flatus without any awareness. Urge incontinence the discharge of faecal matter or flatus despite active attempts to retain these contents Faecal seepage undesired leakage of stool often after a bowel movement with otherwise normal continence and evacuation

Treatments: overview Focus on containment : Pads/Anal plugs Focus on function: Dietary & lifestyle modification Pharmacological Bowel retraining /ASM/PFME +-biofeedback/anal irrigation, SNS, PTNS Focus on structure: Direct anal sphincter repair with levatorplasty Sphincter bulking/implants Artificial anal sphincter

Modifiable risk factors Smoking - effect of nicotine on colonic transit & rectal compliance, 5 fold increase in FI among smokers (Bharucha et al 2012) Obesity - multiple health problems, increased intra abdominal pressure/ PF weakness (Halland & Talley 2012) Diet - role in stool volume & consistency, sources of food intolerance (lactose or gluten), soluble v insoluble fibre, caffeine, alcohol, citrus Lifestyle and toileting behaviour - ameliorate / attenuate IBS

Trans Anal Irrigation system (Peristeen) Qufora Mini system

Neuromodulation Fast growing area of medicine Technology that impacts upon neural interfaces to produce benefit 1 Inherently non-destructive, reversible & adjustable First applied medicinally in 1909: stereotactic brain surgery 2 1. Krames et al., Neuromodulation 2009, Elselvier 2. Horsley V, BMJ 1909 & Cushing H, Brain 1909

Neuromuscular Modulation SNS & PTNS Both effective for FI & UI - SNS associated with complications Advantages of peripheral NM via PN: - indirect stimulation is inherently safe - application can be removed - dose can be adjusted - minimally invasive & well tolerated - potential effect on multiple pelvic organs - cost effective compared to SNS - NICE approved

Sacral Nerve Stimulation Some long term data, N of SN s believed to act at level of efferent motor neuron increased contraction, ASM/PFM pressure Complete continence 41-75% 50% decrease in FI episodes & improved QoL in 75-100%, Invasive, 2-stage procedure, pts must undergo PNE prior to permanent neuro- stimulator implant in upper buttock Expensive, not routinely recommended, requires individual funding application 10 yr cost approx. 19,800 Jarrett et al., Br J Surg 2004, Hetzer et al., Arch Surg 2007, Dudding et al., Br J Surg 2008, Matzel et al., Lancet 2004, Wexner et al., Ann Surg 2010

Pathway of the Tibial Nerve PTNS delivers retrograde access to SN plexus

Urgent PC Neuromodulation System Less invasive NM, alt option to SNS Involves a battery powered, external electrical pulse generator & acupuncture type needle electrode lead set. Total cost approx. 1740.00 (Yr 1 x 15 ) av. 4 top ups (approx. 464.00 Yr 2/3 (exclusive of facilities, clinical & admin support )

Procedure Patient sat comfortably, support treatment leg, insertion site is easily accessible, 3 finger breadths above medial malleolus, 1 finger breadth posterior to tibia 30 minute treatments

Contraindications Urgent PC Pregnant or planning to become pregnant Pacemakers or implantable defibrillators Those prone to excessive bleeding Patients with nerve damage that could impact either percutaneous tibial nerve or pelvic floor function

Treatment Frequency 12 treatments- typically 1 x pw top up to maintain symptom improvement If symptoms reappear or increase in severity, return to treatment frequency providing efficacy Improvement after 6 to 8 treatments Complete 12 sessions before determining effectiveness Measure baseline for comparison (bowel diary, FI score, QOL) Continue with dietary/pharmacological measures

Outcomes Success rate 55-65% Safe & well tolerated Reduced toilet frequency Reduced faecal urgency Greater deferment time Low patient drop out High levels of patient acceptability, satisfaction & dignity Cost effective v containment pads (Hotouras et al Int J colorectal dis ( 2012)

Take home message PTNS treatment well tolerated buys time perception of greater bodily function control emotional benefits- reduces anxiety & frustration- less dependence on locating toilets liberation from pads feels clean more normal lifestyle

Proposed Model for Management Refer all patients to a CNC led clinic Assess and treat Still symptomatic PFD MDT Individualize conservative treatment plan Optimise bladder & bowel function Improve -- discharge Colorectal investigations corrective surgery Urogynaecology investigation corrective surgery 22

Summary FB/PFD has many unmet clinical needs Allow sufficient consultation time Most patients can be effectively managed conservatively Judicial use of range of Tx modalities (TAI, B& B retraining, PFMT +-biofeedback, NM & PTNS Form an important adjunct & may even avoid need for surgery

Thank you